Chemical compounds

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 249/08 (2006.01) A61K 31/4196 (2006.01) A61P 35/00 (2006.01) C07D 401/06 (2006.01)

Patent

CA 2636120

The invention relates to chemical compounds of formula (I) and (II) or pharmaceutically acceptable salts thereof, which possess Edg-1 antagonistic activity and are accordingly useful for their anti cancer activity and thus in methods of treatment of the human or animal body. The invention also relates to processes for the manufacture of said chemical compounds, to pharmaceutical compositions containing them and to their use in the manufacture of medicaments of use in the production of an anti-cancer effect in a warm blooded animal such as man.

L'invention concerne des composés chimiques répondant à la formule (I) et (II) ou leurs sels pharmaceutiquement acceptables, qui possèdent une activité antagonique Edg-1 et sont par conséquent utiles pour leur activité anticancéreuse et ainsi dans des procédés de traitement du corps humain ou animal. L'invention concerne également des procédés de fabrication desdits composés chimiques, des compositions pharmaceutiques les contenant et leur utilisation dans la fabrication de médicaments destinés à une utilisation dans la production d'un effet anticancéreux chez des animaux au sang chaud tel que l'homme.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Chemical compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Chemical compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chemical compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1493927

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.